English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background Event-free survival (EFS) endpoints are composite endpoints frequently used in cancer gene expression studies to evaluate the effects of gene expression on patient outcomes. Event free Survival endpoints in oncology, such as Overall survival, typically combine both cancer-specific ‘death from cancer’ and non-cancer specific events ‘death from other causes’. Reporting analysis on each event comprising the composite endpoint is necessary to draw more specific inferences regarding outcomes, especially in the presence of competing risks. The extent to which cancerspecific and non-specific events are separated in contemporary gene expression studies in oncology is unknown.

Analysis of composite endpoints in gene expression studies in oncology